Want to see IN:MEDANTA full AI Analyst Report?

Global Health Limited (MEDANTA) Price & Analysis

6 Followers

MEDANTA Stock Chart & Stats

₹1370.40

₹36.20(2.64%)

At close: Jul 27 4:00 PM EDT

₹1370.40

₹36.20(2.64%)

Day’s Range― - ―

52-Week Range₹955.20 - ₹1,542.00

Previous CloseN/A

Volume320.04K

Average Volume (3M)54.26K

Market Cap

₹388.65B

Enterprise Value₹259.67K

Total Cash (Recent Filing)₹11.30B

Total Debt (Recent Filing)₹11.90B

Price to Earnings (P/E)68.5

Beta0.67

Next Earnings

Nov 06, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend Yield0.07%

Share Statistics

EPS (TTM)20.71

Shares Outstanding268,871,800

10 Day Avg. Volume83,820

30 Day Avg. Volume54,264

Financial Highlights & Ratios

PEG Ratio2.98

Price to Book (P/B)6.52

Price to Sales (P/S)5.86

P/FCF Ratio-114.57

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

₹1,660.00

Price Target Upside21.13% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering1

EPS Forecast (FY)26.65

Revenue Forecast (FY)₹53.10B

Bulls Say, Bears Say

Bulls Say

Sustained Revenue And Profit GrowthConsistent multi-year revenue expansion and stronger profitability indicate growing demand for Medanta’s healthcare services and improved operating scale, supporting earnings resilience over the medium term.

Improved Balance Sheet LeverageMaterial deleveraging and rising equity have strengthened financial flexibility, reducing balance-sheet risk and improving the company’s capacity to fund hospital expansion and clinical infrastructure.

Improving Operating Cash GenerationImproved operating cash flow suggests that the core hospital network is converting patient-care activity into cash more effectively, providing an important foundation for reinvestment despite recent capital spending.

Bears Say

Negative Latest Free Cash FlowThe shift to negative free cash flow reduces near-term financial flexibility and indicates that investment or spending has outpaced internally generated cash, potentially increasing reliance on funding while expansion continues.

Recent Increase In Total DebtAlthough leverage improved over earlier years, renewed debt growth could raise financing obligations and weaken balance-sheet progress if it persists, particularly while free cash flow remains negative.

Margin VolatilityLower gross profit alongside revenue growth points to mix or cost pressures within hospital operations. If sustained, margin volatility could limit the conversion of strong top-line growth into durable earnings expansion.

Global Health Limited News

Global Health Files ESG-Focused Business Responsibility and Sustainability Report for FY 2025-26

Global Health Limited ( ($IN:MEDANTA) ) has issued an update. Global Health Limited has submitted its Business Responsibility...

15d ago

Global Health Reports Nil Demat Activity for June Quarter Under SEBI Rules

An announcement from Global Health Limited ( ($IN:MEDANTA) ) is now available. Global Health Limited has reported to...

2M ago

Global Health Plans Investor and Analyst Meetings in Late May 2026

An update from Global Health Limited ( ($IN:MEDANTA) ) is now available. Global Health Limited has scheduled meetings...

4M ago

Global Health (Medanta) Schedules Analyst and Institutional Investor Meetings

Global Health Limited ( ($IN:MEDANTA) ) has provided an announcement. Global Health Limited has announced that its management...

4M ago

Global Health Reports No Demat or Remat Activity for March Quarter

Global Health Limited ( ($IN:MEDANTA) ) has issued an update. Global Health Limited has notified the stock exchanges...

5M ago

Global Health Publishes Postal Ballot Voting Results and Scrutinizer’s Report

Global Health Limited ( ($IN:MEDANTA) ) has provided an announcement. Global Health Limited, the operator of Medanta hospitals,...

6M ago

Global Health (Medanta) Receives ESG Rating of 68 for FY2025

Global Health Limited ( ($IN:MEDANTA) ) just unveiled an update. Global Health Limited has disclosed that SES ESG...

8M ago

Global Health Limited Announces Investor and Analyst Meeting Schedule

The latest announcement is out from Global Health Limited ( ($IN:MEDANTA) ). Global Health Limited has announced a...

10M ago

Global Health Limited Schedules Investor Meetings for November 2025

Global Health Limited ( ($IN:MEDANTA) ) has issued an announcement. Global Health Limited has announced a schedule of...

10M ago

Global Health Limited Schedules Investor and Analyst Meetings for November 2025

An update from Global Health Limited ( ($IN:MEDANTA) ) is now available. Global Health Limited has announced a...

10M ago

MEDANTA FAQ

What was Global Health Limited’s price range in the past 12 months?

Global Health Limited lowest stock price was ₹955.20 and its highest was ₹1542.00 in the past 12 months.

What is Global Health Limited’s market cap?

Global Health Limited’s market cap is ₹388.65B.

When is Global Health Limited’s upcoming earnings report date?

Global Health Limited’s upcoming earnings report date is Nov 06, 2026 which is in 62 days.

How were Global Health Limited’s earnings last quarter?

Global Health Limited released its earnings results on Jul 30, 2026. The company reported ₹5.9 earnings per share for the quarter, beating the consensus estimate of ₹5.41 by ₹0.49.

Is Global Health Limited overvalued?

According to Wall Street analysts Global Health Limited’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Global Health Limited pay dividends?

Global Health Limited pays a Notavailable dividend of ₹0.5 which represents an annual dividend yield of 0.07%. See more information on Global Health Limited dividends here

What is Global Health Limited’s EPS estimate?

Global Health Limited’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Global Health Limited have?

Global Health Limited has 268,871,800 shares outstanding.

What happened to Global Health Limited’s price movement after its last earnings report?

Global Health Limited reported an EPS of ₹5.9 in its last earnings report, beating expectations of ₹5.41. Following the earnings report the stock price went down -1.187%.

Which hedge fund is a major shareholder of Global Health Limited?

Currently, no hedge funds are holding shares in IN:MEDANTA

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Global Health Limited

Operating throughout India, Global Health Limited, known by its Medanta brand, stands as a prominent multi-specialty tertiary care provider. The company delivers a comprehensive suite of healthcare services, with particular expertise in cardiology, neurosciences, oncology, digestive and hepatobiliary sciences, orthopedics, liver transplantation, as well as kidney and urology treatments. Established in 2004 and headquartered in Gurgaon, India, it operates a network of four hospitals strategically located in Gurugram, Indore, Ranchi, and Lucknow.

Global Health Limited (MEDANTA) Earnings & Revenues

Historic Earnings Reports

MEDANTA Stock 12 Month Forecast

Average Price Target

₹1,660.00

▲(21.13% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"988":"₹988","1661":"₹1,661","1156.25":"₹1,156.3","1324.5":"₹1,324.5","1492.75":"₹1,492.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":1660,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">₹1.66K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1660,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">₹1.66K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1660,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">₹1.66K</span>\n  </div></div>","useHTML":true}}],"tickPositions":[988,1156.25,1324.5,1492.75,1661],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Dec<br/>2025","6":"Mar<br/>2026","9":"Jun<br/>2026","12":"Sep<br/>2026","25":"Sep<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1456.55,1472.2,1487.85,1503.5,1519.1499999999999,1534.8,1550.45,1566.1,1581.75,1597.4,1613.05,1628.7,1644.35,{"y":1660,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1456.55,1472.2,1487.85,1503.5,1519.1499999999999,1534.8,1550.45,1566.1,1581.75,1597.4,1613.05,1628.7,1644.35,{"y":1660,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1456.55,1472.2,1487.85,1503.5,1519.1499999999999,1534.8,1550.45,1566.1,1581.75,1597.4,1613.05,1628.7,1644.35,{"y":1660,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":1394.755,"date":1756684800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":1305.837,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1313.534,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1244.009,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1191.627,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1139.746,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1127.15,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":989.699,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1117.254,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1167.986,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1327.129,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1407.901,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1456.55,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >